AHPA and CRN express concern about Proposed Rule in Oregon that would create private right of action for opportunistic plaintiffs’ lawyers

Market Alerts

July 2022

June 2022

May 2022

April 2022

February 2022

November 2021

  • SCNM Dedicates Ric Scalzo Institute of Botanical Research
  • August 2021

    July 2021

    March 2021

    February 2021

    November 2020

    October 2020

    September 2020

    August 2020

    July 2020

    June 2020

    April 2020

    February 2020

    January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities
  • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    AHPA and CRN express concern about Proposed Rule in Oregon that would create private right of action for opportunistic plaintiffs’ lawyers

    April 2020: AHPA and CRN urge that Oregon Proposed Rule is unnecessary and should be withdrawn

    Published: Wednesday, April 15, 2020

    AHPA and the Council for Responsible Nutrition (CRN) filed joint comments last week to reiterate significant concerns to the Oregon Department of Justice (OR DOJ) about a Proposed Rule that would create a private right of action for opportunistic plaintiffs' lawyers motivated by the potential for recovery rather than the public interest.

    This Proposed Rule would allow private plaintiffs to initiate a lawsuit simply by alleging – without engaging in scientific evaluation or public interest analysis – that a company making a health benefit claim does not have support for that claim. This would run counter to the well-settled laws of other U.S. jurisdictions and recognized public health considerations as well as the general principle that only regulators can bring a lawsuit based on an alleged lack of substantiation for advertising claims.

    "It is difficult to overstate the immensely harmful effect that the Proposed Rule’s private right of action would have on Oregon businesses," AHPA and CRN stress in the letter to OR DOJ. "The Proposed Rule would have the unintended and undesired consequence of creating a private right of action that opportunistic plaintiffs’ lawyers could abuse to extort Oregon businesses with the threat or initiation of costly and uncertain litigation challenging their substantiation for health benefit claims."

    The letter to OR DOJ emphasizes that AHPA and CRN share the agency's concern about false and fraudulent claims made by opportunists and other bad actors. However, the associations stress that the objectives of the rulemaking could be accomplished by limiting enforcement to Oregon regulators.

    "We understand that the DOJ wishes to move forward promptly with this rulemaking to help combat unsubstantiated product claims ... We applaud this goal generally, but ... the DOJ has already publicly conceded that its current authorities suffice for this purpose," AHPA and CRN state. "The Proposed Rule only stands to harm businesses with the potential to create a flood of frivolous lawsuits from the opportunistic plaintiffs’ bar that could overwhelm Oregon’s court system, while likely providing only marginal additional benefit to the State in achieving its ultimate goal of protecting consumers."

    "At a minimum, we ask that the DOJ limit enforceability of this Proposed Rule to Oregon regulators, but we further urge that the Proposed Rule is unnecessary and should be withdrawn," the letter concludes.

    Print

    2022 Annual Fund Sponsors

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.